The global coronavirus disease 2019 (COVID-19) pandemic has led to the rapid
development of vaccines against this disease. Despite the success of the international …

Large-scale COVID-19 vaccinations are currently underway in many countries in response
to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies …

Introduction While it is established that vaccination reduces risk of hospitalization, there is
conflicting data on whether it improves outcome among hospitalized COVID-19 patients …

The occurrence and course of immune-mediated diseases (IMDs) following COVID-19
vaccination has been little explored so far. We retrieved, among adult patients hospitalized …

COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 and
caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed …

The rate of SARS-CoV-2 infections in vaccinees has become a relevant serious issue. This
study aimed to determine the causes of death, histological organ alteration, and viral spread …

Efficient protection against coronavirus disease 2019 (COVID-19) has been achieved by
immunization with mRNA-based vaccines against severe acute respiratory syndrome …

Severe disease due to COVID-19 has declined dramatically as a result of widespread
vaccination and natural immunity in the population. With the emergence of SARS-CoV-2 …

Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …